HeartBeam (BEAT) Stock Analysis & Winston Score

HeartBeam, Inc. is a small medical technology company focused on heart monitoring. It is developing a credit-card-sized device that lets people record a full 12-lead electrocardiogram (ECG) at home, without going to a hospital. A standard 12-lead ECG is the gold standard for detecting heart attacks and other serious heart problems, and HeartBeam is working to make that level of testing available anywhere.

The company is in the pre-revenue stage, meaning it does not yet sell products and earns essentially no income. HeartBeam is based in the United States and is working to get its device cleared by the FDA before it can be sold to patients and doctors. Its potential moat is its patented technology for reconstructing a full 12-lead ECG from a small handheld device, but the main risk is that it must successfully complete regulatory approval, raise additional funding, and compete against established cardiac monitoring companies to survive.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+33.3% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

19.7%ownership

Insiders own a meaningful stake in the company

Cash Runway

~2 months

$2M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

HeartBeam has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

—

Data not available

Operating Margin

N/A

—

Data not available

ROCE

-742.7%

Weak — -742.7% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

—

Data not available

EPS YoY

N/A

—

Data not available

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial